Inventor
PICHLER LUDWIG
27 patents
⚠️ This page may combine multiple inventors who share the name “PICHLER LUDWIG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BOEHRINGER SOHN INGELHEIM
15 patentsUS4215133AJul 29, 1980
2-[N-(2'-Chloro-4'-methyl-thienyl-3')-N-(cyclopropyl-methyl)-amino]-2-imidazoline and salts thereof
BOEHRINGER SOHN INGELHEIM10 citations74
US4213995AJul 22, 1980
2-Phenylimino-imidazolidines and salts thereof
BOEHRINGER SOHN INGELHEIM11 citations74
US4146645AMar 27, 1979
Hypertensive phenylalkylamines and salts thereof
BOEHRINGER SOHN INGELHEIM8 citations74
US4015011AMar 29, 1977
Phenylalkylamines and salts thereof
BOEHRINGER SOHN INGELHEIM13 citations74
US4361575ANov 30, 1982
Substituted 2-phenylamino-2-imidazolines and salts thereof
BOEHRINGER SOHN INGELHEIM6 citations73
US4293564AOct 6, 1981
2-(3,5-Dibromo-4-amino-phenylimino)-imidazolidine, salts and compositions thereof
BOEHRINGER SOHN INGELHEIM5 citations73
US4259346AMar 31, 1981
Bradycardiac pharmaceutical compositions and method of use
BOEHRINGER SOHN INGELHEIM8 citations73
US4277487AJul 7, 1981
Substituted 2-phenylamino-2-imidazolines as bradycardiacs
BOEHRINGER SOHN INGELHEIM5 citations63
US4250186AFeb 10, 1981
Method of slowing heart rate
BOEHRINGER SOHN INGELHEIM4 citations63
US4210659AJul 1, 1980
Substituted 7-phenyl-2,3-dihydro-imidazo[1,2-α]imidazoles and salts thereof
BOEHRINGER SOHN INGELHEIM4 citations63
US4263300AApr 21, 1981
Substituted 2-phenylamino-1,3-tetrahydro-2-pyrimidines and salts thereof
BOEHRINGER SOHN INGELHEIM2 citations62
US4259342AMar 31, 1981
Antianginal treatment with azepine derivatives
BOEHRINGER SOHN INGELHEIM2 citations57
US4409235AOct 11, 1983
Substituted 7-(2,6-dibromo-4-methyl-phenyl)-2,3-dihydro-imidazo[1,2-a]imidazoles, compositions and use
BOEHRINGER SOHN INGELHEIM0 citations52
US4341788AJul 27, 1982
2-(2-Chloro-4-cyclopropyl-phenyl-imino)-imidazolidine, and acid addition salts thereof as bradycardiacs
BOEHRINGER SOHN INGELHEIM1 citations52
US4271175AJun 2, 1981
Method of using 2-[N-(2,6-dichloro-phenyl)-N-allyl-amino]-2-imidazoline and salts thereof as bradycardiacs
BOEHRINGER SOHN INGELHEIM0 citations52
THOMAE GMBH DR K
6 patentsUS4886812ADec 12, 1989
Tetrahydro-benzthiazoles, the preparation thereof and their use as intermediate products or as pharmaceuticals
THOMAE GMBH DR K130 citations98
US4731374AMar 15, 1988
Tetrahydro-benzthiazoles, the preparation thereof and their use as intermediate products or as pharmaceuticals
THOMAE GMBH DR K129 citations97
US4409220AOct 11, 1983
Fused-ring amino-pyrazines as bradycardiac agents
THOMAE GMBH DR K5 citations74
US4575504AMar 11, 1986
Thienothiazole derivatives
THOMAE GMBH DR K12 citations71
US5068325ANov 26, 1991
4,5,7,8-tetrahydro-6H-thiazolo[5,4-d]azepines, their preparation and their use as pharmaceutical compositions
THOMAE GMBH DR K5 citations62
US4486433ADec 4, 1984
Fused-ring amino-pyrazines as bradycardiacs
THOMAE GMBH DR K0 citations52
IMMUNO AG
5 patentsUS5597800AJan 28, 1997
Treatment with lys-plasminogen of reperfusion injury and brain edema caused by ischemia
IMMUNO AG16 citations82
US5520912AMay 28, 1996
Prevention and treatment of ischemic events and reperfusion injury resulting therefrom using lys-plasminogen
IMMUNO AG17 citations82
US5571786ANov 5, 1996
Use of protein C or the activation peptide of protein C for preparing a pharmaceutical preparation
IMMUNO AG14 citations73
US5549893AAug 27, 1996
Use of protein C in the treatment of purpura fulminans
IMMUNO AG9 citations73
US5675058AOct 7, 1997
Bioassay for thrombogenesis and rabbit model
IMMUNO AG0 citations45